ASIA news

By  Dean Koh 12:02 am March 19, 2019
Founded in 2016, Theranica, a biomedical technology company focused on developing advanced electroceuticals for migraine and other prevalent diseases, yesterday announced the closing of its round B of financing, of $35M, led by aMoon, Israel's largest healthcare VC. All existing investors of the company – Lightspeed Venture Partners, LionBird, Corundum Open Innovation and Takoa – participated in...
By  Dean Koh 12:02 am March 14, 2019
Yesterday, Singapore-based health technology startup CXA Group, which offers an employee benefits and wellness marketplace platform, announced that it has raised $25 million in its latest round of funding. The company’s new group of strategic investors includes HSBC, Singtel Innov8, Telkom Indonesia MDI Ventures, Sumitomo Corporation Equity Asia, Muang Thai Fuchsia Ventures, Humanica and Heritas...
By  Dean Koh 03:56 am March 7, 2019
Gojek an Indonesia-headquartered ride-hailing and logistics company with operations in Indonesia, Vietnam, Singapore and Thailand, today announced that it has partnered with Singapore-based startup Doctor Anywhere, to offer offline and online medical consultations to its drivers. This announcement came after Gojek’s recent tie-up with Gigacover, a Singapore-based insurtech company, which offers...
By  Dean Koh 12:22 am March 5, 2019
Health2Sync and Novo Nordisk Pharma Ltd. are partnering in Japan to support digital diabetes management and facilitate communication between diabetics and healthcare providers. Last December, the two companies agreed to support the localisation and promotion of the “SyncHealth” App (known as Health2Sync outside of Japan) and web platform for patient management. People living with diabetes require...
By  Dean Koh 10:19 pm March 4, 2019
Halodoc, an Indonesia-based health-tech platform, recently announced that it has raised $65M in a series B funding led by new investor UOB Venture Management. Other new investors in the financing round include Singtel Innov8, Korea Investment Partners and WuXi AppTec. Existing investors also participated. The company said the $65M fundraising would be used to develop its technology and...
By  Dean Koh 04:18 am February 28, 2019
China’s one-stop healthcare ecosystem platform, Ping An Good Doctor, yesterday announced its first annual results since listing: the company recorded a revenue of RMB 3.34 billion, representing a year-on-year increase of 78.7%. The three key indicators of the company – registered users, monthly active users (MAU) and monthly paying users (MPU) continued to grow at a rapid rate in 2018. As of...
By  Dean Koh 02:25 am February 25, 2019
The Singapore University of Social Sciences (SUSS) signed a Memorandum of Understanding (MOU) on February 23 with Changi General Hospital Pte Ltd (CGH) and SingHealth Community Hospitals (SCH) to collaborate on various initiatives to better understand and support the needs of the growing silver generation as well as their caregivers. The lowdown Over a period of three years, the three parties...
By  Dean Koh 11:35 pm February 19, 2019
BGN Technologies, the technology transfer company of Ben-Gurion University (BGU), today unveiled an artificial intelligence (AI) platform for monitoring and predicting the progression of neurodegenerative diseases for the purpose of identifying markers for personalised patient care and improved drug development. Developed by Prof. Boaz Lerner of the Department of Industrial Engineering and...
By  Dean Koh 08:23 pm February 19, 2019
Beijing-headquartered clinical genomics testing company, Berry Genomics and Hong Kong and London-headquartered genetics and digital health company Prenetics announced today key management hires for the new company, Circle DNA, which will be operational for business by the end of Q2 2019. The 3 key management hires for Circle DNA are Joe Yan (CEO), Claire Wan (COO) and Candy Liu (Head of Marketing...
By  Dean Koh 04:30 am February 14, 2019
Burning Rock Biotech, which was founded in 2014 and focuses on NGS (Next-Generation Sequencing) diagnostics solutions for precision medicine in oncology, today announced the closing of the Series C financing totaling RMB 850 million. The financing was led by GIC, followed by LYFE Capital, CMB International Capital, Lilly Asia Ventures (LAV), Sequoia Capital China and T&Brothers Capital. The...